−9.90USD
−20.25 MUSD
836.95 K
About vTv Therapeutics Inc.
Sector
CEO
Paul Jai Sekhri
Headquarters
High Point
Website
Employees (FY)
16
Founded
2015
ISIN
US9183852048
FIGI
BBG009DT9XJ0
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VTVT is 24.74 USD — it has increased by 2.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange vTv Therapeutics Inc. stocks are traded under the ticker VTVT.
vTv Therapeutics Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
VTVT stock is 4.00% volatile and has beta coefficient of −0.09. Check out the list of the most volatile stocks — is vTv Therapeutics Inc. there?
VTVT earnings for the last quarter are −3.20 USD whereas the estimation was −3.20 USD which accounts for 0% surprise. Estimated earnings for the next quarter are −2.80 USD. See more details about vTv Therapeutics Inc. earnings.
vTv Therapeutics Inc. revenue for the last quarter amounts to 9.00 K USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 250.00 K USD.
Yes, you can track vTv Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
VTVT stock has fallen by 0.84% compared to the previous week, the month change is a 19.57% rise, over the last year vTv Therapeutics Inc. has showed a 19.68% decrease.
VTVT net income for the last quarter is −3.48 M USD, while the quarter before that showed −6.65 M USD of net income which accounts for 47.73% change. Track more vTv Therapeutics Inc. financial stats to get the full picture.
Today vTv Therapeutics Inc. has the market capitalization of 58.75 M, it has decreased by 2.15% over the last week.
No, VTVT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VTVT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade vTv Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 16.00 employees. See our rating of the largest employees — is vTv Therapeutics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So vTv Therapeutics Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating vTv Therapeutics Inc. stock shows the sell signal. See more of vTv Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.